Mostrar o rexistro simple do ítem
Sofosbuvir/ledipasvir plus ribavirin achieves high SVR12 in genotype‐3 patients with compensated cirrhosis and similar to sofosbuvir plus daclatasvir: a multicentre real life cohort
dc.contributor.author | Riveiro-Barciela, M. | |
dc.contributor.author | Alonso, Sonia | |
dc.contributor.author | Fernández, Inmaculada | |
dc.contributor.author | Rincón, Diego | |
dc.contributor.author | Real, Yolanda | |
dc.contributor.author | Crespo, Javier | |
dc.contributor.author | Gea, Francisco | |
dc.contributor.author | Olveira, Antonio | |
dc.contributor.author | Calleja, J.L. | |
dc.contributor.author | Polo-Lorduy, B. | |
dc.contributor.author | Carrión, J.A. | |
dc.contributor.author | Arenas, J. | |
dc.contributor.author | Devesa, M.J. | |
dc.contributor.author | Baliellas, C. | |
dc.contributor.author | Castro-Iglesias, Ángeles | |
dc.contributor.author | Romero-Gómez, Manuel | |
dc.contributor.author | Granados, R. | |
dc.contributor.author | Pascasio, J.M. | |
dc.contributor.author | Forns, Xavier | |
dc.contributor.author | Turnes, Juan | |
dc.contributor.author | Montero, J.L. | |
dc.contributor.author | Esteban, R. | |
dc.contributor.author | Fernández-Rodríguez, Conrado M. | |
dc.date.accessioned | 2019-02-15T10:20:27Z | |
dc.date.available | 2019-02-15T10:20:27Z | |
dc.date.issued | 2016-10 | |
dc.identifier.citation | Riveiro-Barcela M, Alonso S, Fernández I, et al. Sofosbuvir/ledipasvir plus ribavirin achieves high SVR12 in genotype‐3 patients with compensated cirrhosis and similar to sofosbuvir plus daclatasvir: a multicentre real life cohort. En: The 67th Annual Meeting of the American Association for the Study of Liver Diseases: the Liver Meeting 2016; 2016 Nov 11-15; Boston, Massachusetts. Hoboken, NJ: John Wiley & Sons; 2016. p. 464A (Heaptology. 2016; 64 Special issue 1) | es_ES |
dc.identifier.issn | 0270-9139 | |
dc.identifier.uri | http://hdl.handle.net/2183/21786 | |
dc.description | Poster abstract | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Wiley | es_ES |
dc.relation.uri | https://aasldpubs.onlinelibrary.wiley.com/doi/full/10.1002/hep.28798 | es_ES |
dc.rights | This is the peer reviewed version of the article which has been published in final form at Hepatology. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for self-archiving | es_ES |
dc.title | Sofosbuvir/ledipasvir plus ribavirin achieves high SVR12 in genotype‐3 patients with compensated cirrhosis and similar to sofosbuvir plus daclatasvir: a multicentre real life cohort | es_ES |
dc.type | info:eu-repo/semantics/conferenceObject | es_ES |
dc.rights.access | info:eu-repo/semantics/openAccess | es_ES |
UDC.journalTitle | Hepatology | es_ES |
UDC.volume | 64 | es_ES |
UDC.issue | Special issue 1 | es_ES |
UDC.startPage | 464A | es_ES |
UDC.conferenceTitle | 67th Annual Meeting of the American Association for the Study of Liver Diseases: the liver meeting 2016 | es_ES |